

SMALL-CAP WINNERS & LOSERS: Argo Blockchain plots US dual listing


IN BRIEF: Nuformix annual loss widens on costs to develop pipeline


(Sharecast News) - Nuformix's annual loss widened as revenue fell and the pharmaceutical company spent to development its treatments.


TRADING UPDATES: Alba Mineral in Thule asset boost; Nuformix US patent


TRADING UPDATES: CML plans AIM move; IronRidge to demerge gold assets


EXECUTIVE CHANGES: Gresham House Strategic plots future as chair exits


UK shareholder meetings calendar - next 7 days


Nuformix raises GBP1.6 million via placing to develop NXP002